- Cloud DX (CDX) has been granted C$170,000 to commercialize its Vitaliti and Connected Health innovations
- It received $120,000 as co-recipient of the Synergy Award of Innovation
- It also received $50,000 as a winner of the Ontario Innovation Showcase
- Cloud DX provides a digital and virtual health care platform for remote patient monitoring, aging in place and hospital-quality post-surgical care
- Cloud DX (CDX) is up by 8.82 per cent and is currently trading at $0.185 per share
Cloud DX (CDX) has been granted C$170,000 to commercialize its Vitaliti and Connected Health innovations.
The company’s Connected Health platform was recognized by the Natural Sciences and Engineering Research Council of Canada (NSERC) as co-recipient of its Synergy Award of Innovation.
The platform uses vital signs and physiological data from the Vitaliti monitor to display real-time patient information.
The award provides $100,000 to Sheridan College and $20,000 to the company to continue developing the platform.
Cloud DX was also recognized by the Ontario Center of Innovation as a winner of the Ontario Innovation Showcase. The showcase awarded five winners with $50,000 in direct funding to improve and validate technology that enhances the province’s critical health and security infrastructure.
The awards come just weeks after a previously award-winning project published its findings on improved outcomes through remote monitoring in the prestigious British Journal of Medicine.
Robert Kaul, CEO and Founder of Cloud DX, stated,
“Cloud DX is very proud to accept these awards to support the commercialization of our patented innovations, including Vitaliti and Connected Health, in order to improve health care delivery across North America. Cloud DX will use this new funding to further study the impact remote care has on reducing re-admissions, generating sustainable savings for health care systems and improving patient outcomes.
The NSERC and OCI awards are recognitions of Canadian technology excellence that advance our MedTech industry. Research, testing and published peer-reviewed studies are leading us to the future, one where we see virtual and remote care, AI and augmented reality embedded throughout the health care delivery.”
The company’s upcoming investor meeting is set for noon on December 8, 2021.
Cloud DX provides a digital and virtual health care platform for remote patient monitoring, ageing in place and hospital-quality post-surgical care.
Cloud DX (CDX) is up by 8.82 per cent and is currently trading at $0.185 per share as of 10:39 am ET.
